These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 19247199)
1. Migraine in patients with inflammatory bowel disorders. Ford S; Finkel AG; Isaacs KL J Clin Gastroenterol; 2009; 43(5):499. PubMed ID: 19247199 [No Abstract] [Full Text] [Related]
2. The prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis. Osmanoğlu N; Tekin F; Ozütemiz O; Ersöz G; Tekeşin O Turk J Gastroenterol; 2005 Dec; 16(4):240-1. PubMed ID: 16547857 [No Abstract] [Full Text] [Related]
3. Lack of seasonal variation in menstrually-related migraine. Bekkelund SI; Alstadhaug KB; Salvesen R Cephalalgia; 2008 Dec; 28(12):1277-81. PubMed ID: 18727637 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of migraine in Udo, a rural community in southern Nigeria. Longe AC; Osuntokun BO East Afr Med J; 1988 Sep; 65(9):621-4. PubMed ID: 3265664 [No Abstract] [Full Text] [Related]
5. Patients with an inflammatory bowel disease and narcotic dependence. Gintautas J; Arroyo RA; Ramos L; Present D; Ghattas M; Amanullah S; Fogler RJ Proc West Pharmacol Soc; 2002; 45():71-2. PubMed ID: 12434533 [No Abstract] [Full Text] [Related]
6. Usefulness of a photophobia questionnaire in patients with migraine. Choi JY; Oh K; Kim BJ; Chung CS; Koh SB; Park KW Cephalalgia; 2009 Sep; 29(9):953-9. PubMed ID: 19298545 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Haglund E; Bremander AB; Petersson IF; Strömbeck B; Bergman S; Jacobsson LT; Turkiewicz A; Geborek P; Englund M Ann Rheum Dis; 2011 Jun; 70(6):943-8. PubMed ID: 21288961 [TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of migraine pathology]. Henry P Soins; 2004 Nov; (690):37-8. PubMed ID: 15622640 [No Abstract] [Full Text] [Related]
10. Risk of arterial thrombotic events in inflammatory bowel disease. Ha C; Magowan S; Accortt NA; Chen J; Stone CD Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858 [TBL] [Abstract][Full Text] [Related]
11. Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients. Navarro-Llavat M; Domènech E; Bernal I; Sánchez-Delgado J; Manterola JM; Garcia-Planella E; Mañosa M; Cabré E; Gassull MA Digestion; 2009; 80(1):25-9. PubMed ID: 19439968 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of inflammatory bowel disease across time and countries. An epidemiological study of population-based patient cohorts. Jess T Dan Med Bull; 2008 May; 55(2):103-20. PubMed ID: 19017498 [No Abstract] [Full Text] [Related]
13. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases]. Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449 [TBL] [Abstract][Full Text] [Related]
14. Adolescents with migraine: nature vs nurture. Hershey AD Neurology; 2007 Jul; 69(1):12-3. PubMed ID: 17606876 [No Abstract] [Full Text] [Related]
15. A controlled epidemiological study of the role of psychological factors in migraine. Rees WL Arch Neurobiol (Madr); 1974; 37 SUPPL():243-51. PubMed ID: 4462484 [No Abstract] [Full Text] [Related]
16. Post-traumatic stress disorder is not over-represented in a sample population of migraine patients. Ifergane G; Buskila D; Simiseshvely N; Jotkowitz A; Kaplan Z; Cohen H Eur J Intern Med; 2009 Mar; 20(2):182-5. PubMed ID: 19327609 [TBL] [Abstract][Full Text] [Related]
17. Migraine among university students in Cotonou (Benin). Adoukonou T; Houinato D; Kankouan J; Makoutode M; Paraiso M; Tehindrazanarivelo A; Viader F; Preux PM Headache; 2009 Jun; 49(6):887-93; discussion 894. PubMed ID: 19389138 [TBL] [Abstract][Full Text] [Related]
18. [Migraine-diagnosis and treatment in family practice]. Sigurdardóttir AM; Sigurdsson EL Laeknabladid; 2009 Jun; 95(6):433-8. PubMed ID: 19491408 [TBL] [Abstract][Full Text] [Related]
19. Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study. Shastri YM; Povse N; Schröder O; Stein J Clin Lab; 2008; 54(9-10):389-90. PubMed ID: 19097497 [No Abstract] [Full Text] [Related]